Dennis Langer is Director of Quoin Pharmaceuticals, Ltd.. Currently has a direct ownership of 53 shares of QNRX, which is worth approximately $28. The most recent transaction as insider was on Jun 07, 2024, when has been sold 297 shares (Ordinary Shares) at a price of $0.73 per share, resulting in proceeds of $216. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53
0% 3M change
n/a 12M change
Total Value Held $28

DENNIS LANGER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
SELL
Open market or private sale
$216 $0.73 p/Share
297 Reduced 84.86%
53 Ordinary Shares

Also insider at

MYGN
MYRIAD GENETICS INC Healthcare
BTX
Brooklyn ImmunoTherapeutics, Inc. Healthcare
DL

Dennis Langer

Director
Salt Lake City, UT

Track Institutional and Insider Activities on QNRX

Follow Quoin Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QNRX shares.

Notify only if

Insider Trading

Get notified when an Quoin Pharmaceuticals, Ltd. insider buys or sells QNRX shares.

Notify only if

News

Receive news related to Quoin Pharmaceuticals, Ltd.

Track Activities on QNRX